McGaughy R Kent Jr
Insider CIK 1402856 · APEN Director, 10% owner · RETA Director, 10% owner · PRCT 10% owner · TIL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TIL Instil Bio, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2024-05-03 | 2024-05-07 | 1,785,127 | — | $0 | 2,823,681 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 699 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,300 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 278,309 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 3,109 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 51,095 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 1,692,857 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 690 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 399 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 892 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 9,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 1,844 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 8,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 3,185 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,773 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 4,275 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 1,628 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 4,787 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 11,240 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 25,004 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 2,896,901 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 4,591 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 280 | — | $0 | 0 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 4,275 | — | $0 | 4,275 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 1,628 | $73.68 | $120.0K | 1,628 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-04 | 38,667 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 675,181 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 1,310,701 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 3,687,781 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 63,671 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 400,675 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | D To issuer | 2023-04-04 | 2023-04-04 | 45,594 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | G Gift | 2023-03-03 | 2023-03-07 | 33,217 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion deriv | 2022-12-28 | 2022-12-30 | 0 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion deriv | 2022-12-28 | 2022-12-30 | 0 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion deriv | 2022-12-28 | 2022-12-30 | 0 | — | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion | 2022-12-28 | 2022-12-30 | 586,308 | $3.25 | $1.91M | 1,310,701 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion | 2022-12-28 | 2022-12-30 | 146,577 | $3.25 | $476.4K | 675,181 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | C Conversion | 2022-12-28 | 2022-12-30 | 1,465,770 | $3.25 | $4.76M | 3,687,781 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2022-12-05 | 2022-12-07 | 1,726,534 | — | $0 | 5,029,869 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2022-11-14 | 2022-11-16 | 1,729,482 | — | $0 | 6,993,137 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2022-09-09 | 2022-09-13 | 986,640 | — | $0 | 8,955,675 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2022-09-06 | 2022-09-08 | 743,021 | — | $0 | 10,075,491 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 38,667 | — | $0 | 38,667 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-10 | 4,787 | $24.02 | $115.0K | 4,787 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-10 | 11,240 | — | $0 | 11,240 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | J Other | 2022-03-17 | 2022-03-21 | 304,268 | — | $0 | 10,918,394 | SEC↗ |
| TIL Instil Bio, Inc. | J Other | 2022-03-15 | 2022-03-17 | 260,323 | — | $0 | 8,218,467 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 399 | $16.14 | $6.4K | 399 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2021-10-15 | 2021-10-19 | 387,097 | $7.75 | $3.00M | 2,151,209 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2021-10-15 | 2021-10-19 | 258,064 | $7.75 | $2.00M | 696,071 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2021-10-15 | 2021-10-19 | 38,710 | $7.75 | $300.0K | 521,522 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 3,038,934 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 4,712,969 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 272,205 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 2,060,802 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | P Buy | 2021-09-17 | 2021-09-21 | 440,000 | $25.00 | $11.00M | 11,222,662 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion | 2021-09-17 | 2021-09-21 | 10,084,910 | — | $0 | 10,782,662 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 690 | $83.24 | $57.4K | 690 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion deriv | 2021-03-23 | 2021-03-25 | 795,152 | — | $0 | 0 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion deriv | 2021-03-23 | 2021-03-25 | 5,895,507 | — | $0 | 0 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion | 2021-03-23 | 2021-03-25 | 954,182 | — | $0 | 8,028,790 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion | 2021-03-23 | 2021-03-25 | 7,074,608 | — | $0 | 7,074,608 | SEC↗ |
| TIL Instil Bio, Inc. | P Buy | 2021-03-23 | 2021-03-25 | 450,000 | $20.00 | $9.00M | 8,478,790 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | J Other | 2020-12-23 | 2020-12-29 | 166,666 | — | $0 | 2,896,901 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2020-07-17 | 2020-07-21 | 400,000 | $1.25 | $500.0K | 415,244 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2020-07-17 | 2020-07-21 | 180,000 | $1.25 | $225.0K | 477,120 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2020-07-17 | 2020-07-21 | 1,200,000 | $1.25 | $1.50M | 1,707,208 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-22 | 6,300 | — | $0 | 6,300 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-22 | 699 | $82.15 | $57.4K | 699 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | J Other | 2020-01-02 | 2020-01-06 | 38,108 | — | $0 | 507,208 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | J Other | 2020-01-02 | 2020-01-06 | 15,244 | — | $0 | 15,244 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | J Other | 2020-01-02 | 2020-01-06 | 3,811 | — | $0 | 297,120 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2019-12-12 | 2019-12-16 | 30,478 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2019-12-12 | 2019-12-16 | 30,478 | — | $0 | 33,217 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2019-11-18 | 2019-11-18 | 40,218 | $183.00 | $7.36M | 3,063,567 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy deriv | 2019-08-12 | 2019-08-14 | 0 | $1850000.00 | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy deriv | 2019-08-12 | 2019-08-14 | 0 | $4625000.00 | $0 | 0 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy deriv | 2019-08-12 | 2019-08-14 | 0 | $462500.00 | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-06-12 | 2019-06-14 | 892 | $57.59 | $51.4K | 892 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-06-12 | 2019-06-14 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2018-12-12 | 2018-12-12 | 1,418 | $59.90 | $84.9K | 3,023,349 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2018-12-11 | 2018-12-12 | 52,809 | $60.07 | $3.17M | 3,021,931 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-12 | 26,174 | $57.93 | $1.52M | 2,938,697 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-12 | 1,078 | $58.62 | $63.2K | 2,939,775 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-12 | 29,347 | $59.53 | $1.75M | 2,969,122 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2018-06-13 | 2018-06-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2018-06-13 | 2018-06-15 | 1,844 | $26.49 | $48.8K | 1,844 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-29 | 2017-12-29 | 17,000 | $28.47 | $484.0K | 2,912,523 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-28 | 2017-12-28 | 200 | $26.10 | $5.2K | 2,895,523 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-27 | 2017-12-28 | 15,000 | $25.83 | $387.4K | 2,895,323 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-26 | 2017-12-28 | 12,000 | $26.06 | $312.7K | 2,880,323 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-14 | 2017-12-15 | 78,275 | $24.65 | $1.93M | 2,868,323 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-13 | 2017-12-15 | 300 | $23.98 | $7.2K | 2,790,048 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2017-12-13 | 2017-12-15 | 121,425 | $24.88 | $3.02M | 2,789,748 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 273,770 | $5.50 | $1.51M | 469,100 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 78,965 | $5.50 | $434.3K | 400,675 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 12,548 | $5.50 | $69.0K | 63,671 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 80,276 | $5.50 | $441.5K | 293,309 | SEC↗ |
| APEN Apollo Endosurgery, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 8,986 | $5.50 | $49.4K | 45,594 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2017-06-22 | 2017-06-23 | 742,289 | — | $0 | 1,692,857 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy deriv | 2017-06-22 | 2017-06-23 | 1,200,000 | $25.00 | $30.00M | 2,435,146 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2017-06-22 | 2017-06-23 | 742,289 | — | $0 | 2,668,323 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-06-14 | 2017-06-16 | 3,185 | $17.46 | $55.6K | 3,185 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-06-14 | 2017-06-16 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-12-30 | 2017-01-04 | 9,392 | $21.72 | $204.0K | 1,926,034 | SEC↗ |
| APEN LPATH, INC | J Other | 2016-12-29 | 2016-12-30 | 195,330 | — | $0 | 195,330 | SEC↗ |
| APEN LPATH, INC | J Other | 2016-12-29 | 2016-12-30 | 213,033 | — | $0 | 213,033 | SEC↗ |
| APEN LPATH, INC | J Other | 2016-12-29 | 2016-12-30 | 321,710 | — | $0 | 321,710 | SEC↗ |
| APEN LPATH, INC | J Other | 2016-12-29 | 2016-12-30 | 51,123 | — | $0 | 51,123 | SEC↗ |
| APEN LPATH, INC | J Other | 2016-12-29 | 2016-12-30 | 36,608 | — | $0 | 36,608 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-12-16 | 2016-12-20 | 164,753 | $22.99 | $3.79M | 1,916,642 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-12-15 | 2016-12-16 | 2,700 | $22.05 | $59.5K | 1,751,889 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-12-14 | 2016-12-16 | 6,189 | $21.37 | $132.3K | 1,749,189 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2016-12-07 | 2016-12-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2016-12-07 | 2016-12-08 | 2,773 | $14.54 | $40.3K | 2,773 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-08-18 | 2016-08-18 | 105,562 | $17.32 | $1.83M | 1,743,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-08-17 | 2016-08-18 | 144,058 | $17.26 | $2.49M | 1,637,438 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-08-16 | 2016-08-18 | 58,600 | $16.21 | $949.9K | 1,493,380 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-30 | 2016-06-30 | 100,000 | $19.75 | $1.98M | 632,780 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-29 | 2016-06-30 | 63,700 | $19.83 | $1.26M | 532,780 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-28 | 2016-06-30 | 900 | $19.74 | $17.8K | 469,080 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-27 | 2016-06-28 | 21,968 | $19.17 | $421.1K | 468,180 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-24 | 2016-06-28 | 8,909 | $18.35 | $163.5K | 403,686 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-24 | 2016-06-28 | 42,526 | $19.49 | $828.8K | 446,212 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-07 | 2016-06-08 | 4,220 | $17.62 | $74.4K | 394,777 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-06 | 2016-06-08 | 20,000 | $17.56 | $351.2K | 390,557 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-08-09 | 802,000 | $11.00 | $8.82M | 912,969 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2016-06-01 | 2016-06-01 | 2,739 | — | $0 | 30,478 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2016-06-01 | 2016-06-01 | 110,969 | — | $0 | 1,235,146 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2016-06-01 | 2016-06-01 | 25,004 | — | $0 | 278,309 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2016-06-01 | 2016-06-01 | 4,591 | — | $0 | 51,095 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2016-06-01 | 2016-06-01 | 280 | — | $0 | 3,109 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2016-06-01 | 2016-06-01 | 25,004 | — | $0 | 25,004 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2016-06-01 | 2016-06-01 | 4,591 | — | $0 | 4,591 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2016-06-01 | 2016-06-01 | 280 | — | $0 | 280 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2016-06-01 | 2016-06-01 | 2,739 | — | $0 | 2,739 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2016-06-01 | 2016-06-01 | 110,969 | — | $0 | 110,969 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 56,739 | $11.43 | $648.5K | 167,708 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 127,691 | $12.76 | $1.63M | 295,399 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 8,233 | $13.22 | $108.8K | 303,632 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 28,797 | $13.26 | $381.8K | 332,429 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 23,890 | $14.11 | $337.1K | 362,522 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-01 | 6,203 | $14.22 | $88.2K | 338,632 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | P Buy | 2016-06-01 | 2016-06-03 | 8,035 | $13.42 | $107.8K | 370,557 | SEC↗ |